Endocrinology Research and Practice
Original Article

Effect of Gibberellic Acid on the Levels of Tumor Necrosis Factor-α, Interleukin-4 and Interleukin-10 in Rats

1.

University of Health Sciences, Ankara Dışkapı Training and Research Hospital, Department of Hematology, Ankara, Turkey

2.

Akdeniz University Faculty of Medicine, Department of Medical Pharmacology, Antalya, Turkey

3.

Akdeniz University Faculty of Medicine, Division of Endocrinology and Metabolism, Antalya, Turkey

Endocrinol Res Pract 2019; 23: 150-157
DOI: 10.25179/tjem.2019-65107
Read: 1874 Downloads: 486 Published: 01 September 2019

ABSTRACT

Objective: Gibberellic acid is a plant growth factor. Several studies have demonstrated the effect of gibberellic acid on tumor development. Tumor necrosis factor-α, interleukin-4 and interleukin-10 are important cytokines involved in the regulation or prevention of cancer. The aim of this study was to investigate whether changes in cytokine balance have any role in the tumor-inducing effect of gibberellic acid.

Material and Methods: In order to examine the acute and subchronic effect of gibberellic acid, 50 male Wistar rats were divided into five groups. For the subchronic treatments, the first group received 2 mg/kg gibberellic acid, the second group received 20 mg/kg gibberellic acid, and the third group received only the solvent via intraperitoneal injections given three times a week for a 30 days. In the acute treatment group, a single does of either 20 mg/kg gibberellic acid or the solvent alone was administered via intraperitoneal injection, and the tissues were dissected three hours after the injection.

Results: During the study period (30 days), both doses of gibberellic acid resulted in a decrease in Tumor necrosis factor- α levels, and a dose-dependent decrease in interleukin- 4 levels was observed. However, no change was observed in interleukin-10 levels.

Conclusion: We conclude that gibberellic acid influenced the cytokine balance. The resulting changes may be responsible for the development or advancement of inflammatory diseases and malignancies.

 

 

Files
EISSN 2822-6135